Last reviewed · How we verify
Placebo for Prednisolon
A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.
A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Control arm in Phase 3 clinical trial comparing prednisolone efficacy.
At a glance
| Generic name | Placebo for Prednisolon |
|---|---|
| Also known as | N.I. |
| Sponsor | Wuerzburg University Hospital |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebos are inert substances used as controls in clinical trials to establish the efficacy of an active drug by comparison. Any observed effects in placebo groups are attributed to the placebo effect—psychological and physiological responses driven by patient expectation rather than pharmacological action. In this Phase 3 trial context, the placebo serves as the control arm against which prednisolone efficacy is measured.
Approved indications
- Control arm in Phase 3 clinical trial comparing prednisolone efficacy
Common side effects
Key clinical trials
- Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome (PHASE3)
- The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance (NA)
- Comparison of the Effectiveness of Two Different Dosages of Cortisone Compared to Placebo in Rheumatoid Arthritis (PHASE3)
- Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants (PHASE2)
- The Effect of Moderate-Dose Steroid Therapy in Sepsis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |